Pricing
  1. JP-listed companies
  2. Ina Research Inc.
  3. Financials
  4. Stockholders' equity

Ina Research Inc. (E20922)

Market cap
P/E ratio
Inari Research provides contract testing services to help pharmaceutical companies evaluate drug safety and effectiveness using GLP-compliant laboratory facilities.
SummaryFinancialsDividendsHistoryWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Mar 31, 20221,364+32.24%
Mar 31, 20211,031+29.15%
Mar 31, 2020799+4.80%
Mar 31, 2019762+8.04%
Mar 31, 2018705+25.86%
Mar 31, 2017560+3.39%
Mar 31, 2016542-71.13%
Mar 31, 20151,877-0.50%
Mar 31, 20141,887+5.35%
Mar 31, 20131,791-0.69%
Mar 31, 20121,803

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat